Comment
-
PBAC harmony? That’s a matter of perspective
- Fri Sep 11
OP-ED: Broad funding of immunotherapies is a story of collaboration says Prof Robyn Ward, but given the time it took, is this really what success looks like?
Read more -
Courageously ambitious or completely delusional?
- Fri Sep 4
Medicines Australia’s list of asks is likely to be met with chuckles of incredulity in the corridors of Canberra, but the industry association has shown it means business.
Read more -
Diabetes points the way to AI’s future in healthcare
- Wed Aug 19
AI is already transforming diabetes prevention, diagnosis and care, demonstrating how Australian healthcare can benefit from AI adoption.
Read more -
Thanks so much for making me unemployed
- Wed Aug 12
OP-ED: Ex-pharma employees are taking to social media in droves to announce how thrilled they are to be made redundant, but are those left behind any better off?
Read more -
Respect goes both ways – even with media
- Fri Aug 7
OP-ED: A recent incident made me ponder the meaning of respect, particularly as it relates to journalism and the role of the Fourth Estate.
Read more -
What are we really missing out on?
- Wed Jul 22
Medicines Australia’s new report contains a list of medicines it claims Australia should fund, but we found a number of therapies on the list hard to justify.
Read more -
Move over Big Pharma, media has a new villain
- Mon Jul 20
OP-ED: The Australian media has been unusually kind to pharma of late. Unfortunately for the TGA and medtech, Nine media have found a new target.
Read more -
Guild gets by with a little help from a friend
- Wed Jul 15
The high-profile spokesperson for a patient organisation housed in the same premises opposes a controversial proposal to allow prescription meds in supermarkets.
Read more